GRC-5XXX

N/A

Report date: 2025/01/26 18:35:51
NME

Base Information

Drug NameGRC-5XXX
Drug Alias NameMAP4K1 inhibitor (Glenmark/APC Therapeutics)GRC-5XXX
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase kinase kinase kinase 1 inhibitors
TargetsMitogen-activated protein kinase kinase kinase kinase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAPC Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesGlenmark Pharmaceuticals Sa
Inactive CompaniesAPC Therapeutics Inc
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A